January 4, 2018 / 8:12 AM / a year ago

BRIEF-Acacia Pharma Announces Fda Acceptance Of Nda Filing For Baremsis® For The Management Of Post-Operative Nausea & Vomiting

Jan 4 (Reuters) - Acacia Pharma Ltd IPO-ACAC.L:

* ACACIA PHARMA ANNOUNCES FDA ACCEPTANCE OF NDA FILING FOR BAREMSIS® FOR THE MANAGEMENT OF POST-OPERATIVE NAUSEA & VOMITING

* ‍UNDER PRESCRIPTION DRUG USER FEE ACT (PDUFA), FDA HAS SET A TARGET DATE OF 5TH OCTOBER 2018 TO COMPLETE ITS REVIEW​ Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below